{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:08:57Z","timestamp":1792789737022,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.radonc.2023.109889","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T02:20:58Z","timestamp":1693534858000},"page":"109889","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment"],"prefix":"10.1016","volume":"188","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3513-6544","authenticated-orcid":false,"given":"Gerda M.","family":"Verduijn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7928-1578","authenticated-orcid":false,"given":"Nienke D.","family":"Sijtsema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvette","family":"van Norden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2144-0729","authenticated-orcid":false,"given":"Wilma D.","family":"Heemsbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0559-543X","authenticated-orcid":false,"given":"Hetty","family":"Mast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aniel","family":"Sewnaik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denzel","family":"Chin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta E.","family":"Capala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aad","family":"van der Lugt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"van Meerten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4264-9903","authenticated-orcid":false,"given":"Mischa S.","family":"Hoogeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9787-8239","authenticated-orcid":false,"given":"Steven F.","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2023.109889_b0005","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1046\/j.1365-2273.2000.00367.x","article-title":"Mandibular osteoradionecrosis: clinical behaviour and diagnostic aspects","volume":"25","author":"St\u00f8re","year":"2000","journal-title":"Clin Otolaryngol Allied Sci"},{"key":"10.1016\/j.radonc.2023.109889_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1053\/ctrv.2002.0254","article-title":"Radiotherapy-induced mandibular bone complications","volume":"28","author":"Jereczek-Fossa","year":"2002","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.radonc.2023.109889_b0015","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00000421-200204000-00013","article-title":"Osteoradionecrosis of the mandible: scientific basis for clinical staging","volume":"25","author":"Schwartz","year":"2002","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0020","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.oraloncology.2017.07.014","article-title":"Incidence of, and risk factors for, mandibular osteoradionecrosis in patients with oral cavity and oropharynx cancers","volume":"72","author":"Moon","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0025","doi-asserted-by":"crossref","unstructured":"Head MDA, Neck Cancer Symptom Working G. Dose-volume correlates of mandibular osteoradionecrosis in Oropharynx cancer patients receiving intensity-modulated radiotherapy: Results from a case-matched comparison. Radiother Oncol. 2017;124:232-9.","DOI":"10.1016\/j.radonc.2017.06.026"},{"key":"10.1016\/j.radonc.2023.109889_b0030","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1002\/hed.24505","article-title":"Comparison of the incidence of osteoradionecrosis with conventional radiotherapy and intensity-modulated radiotherapy","volume":"38","author":"Maesschalck","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2023.109889_b0035","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.radonc.2017.05.006","article-title":"Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer","volume":"123","author":"Zhang","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0040","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.ijrobp.2021.04.042","article-title":"Normal Tissue Complication Probability (NTCP) prediction model for osteoradionecrosis of the mandible in patients with head and neck cancer after radiation therapy: large-scale observational cohort","volume":"111","author":"van Dijk","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0045","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ijrobp.2012.05.032","article-title":"Osteoradionecrosis and radiation dose to the mandible in patients with oropharyngeal cancer","volume":"85","author":"Tsai","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0050","doi-asserted-by":"crossref","first-page":"3691","DOI":"10.1002\/cncr.30803","article-title":"Osteoradionecrosis of the mandible in patients with oropharyngeal carcinoma treated with intensity-modulated radiotherapy","volume":"123","author":"Caparrotti","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109889_b0055","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.oraloncology.2016.11.015","article-title":"The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience","volume":"64","author":"Owosho","year":"2017","journal-title":"Oral Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0060","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1080\/0284186X.2019.1643037","article-title":"Osteoradionecrosis of the mandible after radiotherapy for head and neck cancer: risk factors and dose-volume correlations","volume":"58","author":"Aarup-Kristensen","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0065","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1148\/119.3.665","article-title":"Osteonecrosis in patients treated with definitive radiotherapy for squamous cell carcinomas of the oral cavity and naso-and oropharynx","volume":"119","author":"Bedwinek","year":"1976","journal-title":"Radiology"},{"key":"10.1016\/j.radonc.2023.109889_b0070","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ijrobp.2006.11.059","article-title":"Lack of osteoradionecrosis of the mandible after intensity-modulated radiotherapy for head and neck cancer: likely contributions of both dental care and improved dose distributions","volume":"68","author":"Ben-David","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0075","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.radonc.2022.10.011","article-title":"Osteoradionecrosis rate in oropharynx cancer treated with dose volume histogram based constraints","volume":"176","author":"Lee","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0080","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ijrobp.2015.06.016","article-title":"Single vocal cord irradiation: image guided intensity modulated hypofractionated radiation therapy for T1a glottic cancer: early clinical results","volume":"93","author":"Al-Mamgani","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0085","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.ijrobp.2019.02.025","article-title":"Optimized Hypofractionation Can Markedly Improve Tumor Control and Decrease Late Effects for Head and Neck Cancer","volume":"104","author":"Shuryak","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0090","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1002\/cncr.32968","article-title":"Hypofractionated radiotherapy alone with 2.4 Gy per fraction for head and neck cancer during the COVID-19 pandemic: the Princess Margaret experience and proposal","volume":"126","author":"Huang","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2023.109889_b0095","doi-asserted-by":"crossref","unstructured":"Elbers JBW. HYpofractionated, Dose-redistributed RAdiotherapy with protons and photons to combat radiation-induced immunosuppression in head and neck squamous cell carcinoma: study protocol of the phase-I HYDRA trial; 2023.","DOI":"10.21203\/rs.3.rs-2409935\/v1"},{"key":"10.1016\/j.radonc.2023.109889_b0100","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0360-3016(95)00229-R","article-title":"Late normal tissue sequelae from radiation therapy for carcinoma of the tonsil: patterns of fractionation study of radiobiology","volume":"33","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0105","unstructured":"NVMKA. Richtlijn Mondholte- en Orofarynxcarcinoom. Nederlandse Vereniging voor Mondziekten, Kaak- en Aangezichtschirurgie; 2004. https:\/\/www.nvmka.nl\/sites\/www.nvmka.nl\/files\/Richtlijn-Mondholte--en-Orofarynxcarcinoom.pdf."},{"key":"10.1016\/j.radonc.2023.109889_b0110","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S1470-2045(06)70658-1","article-title":"Radiation-related damage to dentition","volume":"7","author":"Kielbassa","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0115","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1118\/1.598063","article-title":"Reporting and analyzing dose distributions: a concept of equivalent uniform dose","volume":"24","author":"Niemierko","year":"1997","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0120","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0360-3016(01)02585-8","article-title":"Optimization of intensity-modulated radiotherapy plans based on the equivalent uniform dose","volume":"52","author":"Wu","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0125","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1118\/1.1897464","article-title":"Dose sculpting with generalized equivalent uniform dose","volume":"32","author":"Wu","year":"2005","journal-title":"Med Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0130","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/j.ijrobp.2004.11.039","article-title":"Method to account for dose fractionation in analysis of IMRT plans: modified equivalent uniform dose","volume":"62","author":"Park","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0135","doi-asserted-by":"crossref","first-page":"4514","DOI":"10.1120\/jacmp.v15i4.4514","article-title":"Efficiency of biological versus physical optimization for single-arc VMAT for prostate and head and neck cases","volume":"15","author":"Pyshniak","year":"2014","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0140","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.meddos.2022.02.001","article-title":"Various cost functions evaluation of commercial biologically based treatment planning system for nasopharyngeal cancer","volume":"47","author":"Can","year":"2022","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2023.109889_b0145","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/hed.20538","article-title":"Do pre-irradiation dental extractions reduce the risk of osteoradionecrosis of the mandible?","volume":"29","author":"Chang","year":"2007","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2023.109889_b0150","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hed.24761","article-title":"Risk factors for and the role of dental extractions in osteoradionecrosis of the jaws: a national-based cohort study","volume":"39","author":"Wang","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2023.109889_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109736","article-title":"Development of a local dose-response relationship for osteoradionecrosis within the mandible","volume":"186","author":"Sijtsema","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0160","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1080\/02841860902740899","article-title":"Hypofractionated radiotherapy denoted as the \u201cChristie scheme\u201d: an effective means of palliating patients with head and neck cancers not suitable for curative treatment","volume":"48","author":"Al-Mamgani","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0165","doi-asserted-by":"crossref","first-page":"214","DOI":"10.3389\/fonc.2014.00214","article-title":"Stereotactic body radiotherapy as primary treatment for elderly patients with medically inoperable head and neck cancer","volume":"4","author":"Vargo","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0170","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3389\/fonc.2018.00206","article-title":"An extended hypofractionated palliative radiotherapy regimen for head and neck carcinomas","volume":"8","author":"Laursen","year":"2018","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0175","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.ijrobp.2009.04.011","article-title":"Multi-institutional trial of accelerated hypofractionated intensity-modulated radiation therapy for early-stage oropharyngeal cancer (RTOG 00\u201322)","volume":"76","author":"Eisbruch","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2023.109889_b0180","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1748-717X-7-85","article-title":"Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment","volume":"7","author":"Lee","year":"2012","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0185","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3389\/fonc.2014.00268","article-title":"IMRT with stereotactic body radiotherapy boost for high risk malignant salivary gland malignancies: a case series","volume":"4","author":"Karam","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0190","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1080\/0284186X.2019.1581375","article-title":"Long-term outcomes following stereotactic body radiotherapy boost for oropharyngeal squamous cell carcinoma","volume":"58","author":"Baker","year":"2019","journal-title":"Acta Oncol"},{"key":"10.1016\/j.radonc.2023.109889_b0195","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1002\/hed.26948","article-title":"Stereotactic radiotherapy as planned boost after definitive radiotherapy for head and neck cancers: systematic review","volume":"44","author":"Kim","year":"2022","journal-title":"Head Neck"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814023897833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T05:28:01Z","timestamp":1759123681000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814023897833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":39,"alternative-id":["S0167814023897833"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109889","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Accounting for fractionation and heterogeneous dose distributions in the modelling of osteoradionecrosis in oropharyngeal carcinoma treatment","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2023.109889","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"109889"}}